Clinical Trials Browser

Hyperinsulinism × Breast × 90 days × Clear all

NCT05989347 2026-05-22

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism

NCT05455619 2026-04-22

Amelia-1

Phase 1/2 Recruiting

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance